Previous 10 | Next 10 |
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Correvio Pharma Corporation (“Correvio” or the “Company”) (NASDAQ: CORV ) investors concerning the Company and its officers’ possible violations of federal securit...
New York, New York--(Newsfile Corp. - December 17, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Correvio Pharma Corp. (NASDAQ: CORV) ("Correvio" or the "Company") of the February 10, 2020 deadline to seek the role of lead plaintiff in a federal...
ACADIA Pharmaceuticals (NASDAQ: ACAD ) initiated with Buy rating and $60 (35% upside) price target at Guggenheim. Shares up a fraction premarket. More news on: ACADIA Pharmaceuticals Inc., Aurora Cannabis Inc., Pluristem Therapeutics Inc., Healthcare stocks news, Stocks on the move, , ...
Gainers: Camber Energy (NYSEMKT: CEI ) +130% . More news on: Camber Energy, Inc., Marinus Pharmaceuticals, Inc., Centogene N.V., Stocks on the move, Read more ...
Correvio Pharma (NASDAQ: CORV ) -59% after FDA advisory committee thumbs down on Brinavess. More news on: Correvio Pharma Corp., Iterum Therapeutics plc, GameStop Corp., Stocks on the move, Read more ...
Correvio Pharma (NASDAQ: CORV ) plans to explore strategic alternatives after yesterday's negative vote from an FDA advisory committee on its application for Brinavess for the rapid conversion of recent onset atrial fibrillation in adults. More news on: Correvio Pharma Corp.,...
Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value Canada NewsWire VANCOUVER, Dec. 11, 2019 NASDAQ: CORV TSX: CORV VANCOUVER , Dec. 11, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pha...
AdaptHealth (NASDAQ: AHCO ) initiated with Outperform rating and $13 (30% upside) price target at SVB Leerink. More news on: AdaptHealth Corp., CryoLife, Inc., Acadia Healthcare Company, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Correvio Announces Outcome Of FDA Advisory Committee Meeting Reviewing Brinavess™ For The Treatment Of Recent Onset Atrial Fibrillation Canada NewsWire VANCOUVER, Dec. 10, 2019 NASDAQ: CORV TSX: CORV VANCOUVER , Dec. 10, 2019 /CNW/ - Correvio ...
NASDAQ: CORV TSX: CORV VANCOUVER , Dec. 10, 2019 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that NASDAQ and the Toronto Stock Exchange (TSX) have halted trad...
News, Short Squeeze, Breakout and More Instantly...
Correvio Pharma Corp. Company Name:
CORV Stock Symbol:
NASDAQ Market:
Correvio Pharma Corp. Website:
NASDAQ: CORV TSX: CORV VANCOUVER , May 21, 2020 /PRNewswire/ - Correvio Pharma Corp. (" Correvio " or the " Company ") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has obtained a final order...
Correvio Announces Results from Annual General and Special Meeting of Securityholders Canada NewsWire VANCOUVER, May 15, 2020 Securityholders Approve ADVANZ PHARMA Acquisition NASDAQ: CORV TSX: CORV VANCOUVER , May 15, 2020 /CNW/ - Correvio Pharma Cor...
NASDAQ: CORV TSX: CORV VANCOUVER , May 6, 2020 /PRNewswire/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), today announced that Glass, Lewis & Co., LLC ("Glass Lewis"), a leading independent proxy advisory firm, released a report...